2021 CMSC Annual Meeting

Tag: 7302DMT53Poster-Disease-modifying TherapyPatricia K. Coyle

Poster-Disease-modifying Therapy

Multiple Sclerosis Patients Initiating Ofatumumab in the Real-World: Early 3 Months Data

Background: The efficacy and safety of ofatumumab were demonstrated in Phase III ASCLEPIOS trials. This analysis provides the first account...

Read More